We are live on ! Find out more
S

SignatureFD Portfolio holdings

AUM $7.49B
1-Year Est. Return 24.82%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+24.82%
3 Year Est. Return
+73.56%
5 Year Est. Return
+79.97%
10 Year Est. Return
+256.52%
AUM
$2.51B
AUM Growth
+$246M
Cap. Flow
+$146M
Cap. Flow %
5.81%
Top 10 Hldgs %
61.67%
Holding
3,166
New
364
Increased
1,456
Reduced
496
Closed
157

Top Buys

Rank Stock Value
1
IUSV icon
iShares Core S&P US Value ETF
IUSV
+$48.7M
2
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$24.6M
3
VLUE icon
iShares MSCI USA Value Factor ETF
VLUE
+$5.98M
4
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$5.47M
5
VIG icon
Vanguard Dividend Appreciation ETF
VIG
+$5.44M

Top Sells

Rank Stock Value
1
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$40.5M
2
USMV icon
iShares MSCI USA Min Vol Factor ETF
USMV
+$8.98M
3
OEF icon
iShares S&P 100 ETF
OEF
+$4.52M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.55M
5
AXS icon
AXIS Capital
AXS
+$1.51M

Sector Composition

Rank Sector Weight
1 Technology 7.52%
2 Consumer Discretionary 5.28%
3 Financials 4.29%
4 Healthcare 3.52%
5 Communication Services 2.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NBHC icon
2601
National Bank Holdings
NBHC
$1.9B
$2K ﹤0.01%
40
– –
NNI icon
2602
Nelnet
NNI
$4.96B
$2K ﹤0.01%
23
– –
NVEC icon
2603
NVE Corp
NVEC
$543M
$2K ﹤0.01%
26
+17
+189% +$1.21K
NX icon
2604
Quanex
NX
$825M
$2K ﹤0.01%
62
-66
-52% -$1.76K
OCUL icon
2605
Ocular Therapeutix
OCUL
$1.83B
$2K ﹤0.01%
134
– –
PCRX icon
2606
Pacira BioSciences
PCRX
$1.04B
$2K ﹤0.01%
31
– –
PCY icon
2607
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.38B
$2K ﹤0.01%
85
+23
+37% +$632
PRPL icon
2608
Purple Innovation
PRPL
$34.5M
$2K ﹤0.01%
3
+2
+200% +$1.53K
PRQR icon
2609
ProQR Therapeutics
PRQR
$244M
$2K ﹤0.01%
+290
New +$1.87K
PTGX icon
2610
Protagonist Therapeutics
PTGX
$8.55B
$2K ﹤0.01%
46
– –
HTT
2611
High Templar Tech Ltd
HTT
$370M
$2K ﹤0.01%
+816
New +$1.75K
QTRX icon
2612
Quanterix
QTRX
$159M
$2K ﹤0.01%
35
+24
+218% +$1.39K
RPRX icon
2613
Royalty Pharma
RPRX
$26.2B
$2K ﹤0.01%
52
+5
+11% +$213
RWO icon
2614
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.32B
$2K ﹤0.01%
42
+1
+2% +$51
SAFT icon
2615
Safety Insurance
SAFT
$1.51B
$2K ﹤0.01%
21
– –
SHM icon
2616
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.47B
$2K ﹤0.01%
37
-1,250
-97% -$62K
SLDB icon
2617
Solid Biosciences
SLDB
$792M
$2K ﹤0.01%
+29
New +$1.92K
SLP icon
2618
Simulations Plus
SLP
$371M
$2K ﹤0.01%
30
-66
-69% -$3.78K
SOHU
2619
Sohu.com
SOHU
$352M
$2K ﹤0.01%
101
– –
SPSM icon
2620
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$16.9B
$2K ﹤0.01%
39
– –
SSYS icon
2621
Stratasys
SSYS
$666M
$2K ﹤0.01%
76
– –
TBPH icon
2622
Theravance Biopharma
TBPH
$873M
$2K ﹤0.01%
160
-198
-55% -$3.72K
TCX icon
2623
Tucows
TCX
$104M
$2K ﹤0.01%
19
+4
+27% +$317
TDC icon
2624
Teradata
TDC
$2.88B
$2K ﹤0.01%
+43
New +$1.96K
TGB
2625
Trekor Metals
TGB
$2.45B
$2K ﹤0.01%
+776
New +$1.67K
103 104
105
106 107

Similar funds

JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
YAM
Yacktman Asset Management Austin, Texas $7.5B AUM 22.48% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
SP
SIH Partners Wilmington, Delaware $7.58B AUM 5.28% 1-Year Est. Return
BIM
Bridges Investment Management Omaha, Nebraska $7.38B AUM 15.39% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

SignatureFD's Q2 2021 Portfolio in Review

As of Q2 2021, SignatureFD held 3,166 positions worth $2.51B, up 11% from $2.26B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

SignatureFD deployed $146M of net new capital in Q2 2021, opening 364 new positions and adding to 1,456 existing holdings. Its largest new stake was Danimer Scientific, Inc.: 1,202 shares worth $1.2M.

By sector, the portfolio is most concentrated in Technology at 7.5% of assets, up from 6.9% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 1000 Growth ETF, an estimated $40.5M trimmed.

  • SignatureFD's largest Q2 2021 buy was Danimer Scientific, Inc.: 1,202 shares worth $1.2M.
  • SignatureFD added most to iShares Core S&P US Value ETF in Q2 2021, an estimated $48.7M increase.
  • SignatureFD's biggest Q2 2021 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $40.5M.
  • SignatureFD fully exited WisdomTree US Value Fund in Q2 2021, selling an estimated $269K.
  • SignatureFD's ten largest holdings make up 62% of its $2.51B portfolio in Q2 2021.
  • SignatureFD opened 364 new positions and closed 157 in Q2 2021.
  • SignatureFD's portfolio value rose 11% quarter-over-quarter to $2.51B.

Based on SignatureFD's 13F filing for Q2 2021, filed 26 Jul 2021.